(Q74183645)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12032740%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

0 references

1 reference

title

Herbal simulation of ephedrine and caffeine in treatment of obesity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12032740%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12032740%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

publication date

1 May 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12032740%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12032740%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12032740%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

590-592

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12032740%20AND%20SRC:MED&resulttype=core&format=json

Poststarvation hyperphagia and body fat overshooting in humans: a role for feedback signals from lean and fat tissues

9 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802036

7 January 2021

Adaptive reduction in basal metabolic rate in response to food deprivation in humans: a role for feedback signals from fat stores

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802036

7 January 2021

Is an ephedrine caffeine treatment contraindicated in hypertension?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802036

7 January 2021

Safety and efficacy of treatment with an ephedrine/caffeine mixture. The first double-blind placebo-controlled pilot study in adolescents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802036

7 January 2021

The effect of ephedrine/caffeine mixture on energy expenditure and body composition in obese women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802036

7 January 2021

Pharmaceutical cost savings of treating obesity with weight loss medications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802036

7 January 2021

Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802036

7 January 2021

The safety and efficacy of pharmaceutical and herbal caffeine and ephedrine use as a weight loss agent

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802036

7 January 2021

Combined drug treatment of obesity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802036

7 January 2021

Cardiovascular differences between phenylpropanolamine and its related norephedrine isomers in the rat

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802036

7 January 2021

An herbal supplement containing Ma Huang-Guarana for weight loss: a randomized, double-blind trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802036

7 January 2021

Herbal ephedra/caffeine for weight loss: a 6-month randomized safety and efficacy trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802036

7 January 2021

Identifiers

DOI

10.1038/SJ.IJO.0802036

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12032740%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference